title: miR-25 in heart failure.
authors.affiliation: From miRagen Therapeutics, Inc, Boulder, CO (E.W.B.); and Hubrecht Institute, KNAW, University Medical Center Utrecht, Utrecht, The Netherlands (E.v.R.).
authors.forename: Erik W
authors.initials: EW
authors.lastname: Bush
authors.affiliation: From miRagen Therapeutics, Inc, Boulder, CO (E.W.B.); and Hubrecht Institute, KNAW, University Medical Center Utrecht, Utrecht, The Netherlands (E.v.R.). E.vanrooij@hubrecht.eu.
authors.forename: Eva
authors.initials: E
authors.lastname: van Rooij
mesh_terms: D000818:Animals; D006333:Heart Failure / Q000235:genetics* / Q000628:therapy*; D006801:Humans; D008297:Male; D035683:MicroRNAs / Q000037:antagonists & inhibitors*; D009200:Myocardial Contraction / Q000187:drug effects*
chemical_list: D035683:MicroRNAs